PALM BEACH GARDENS, Fla.--(BUSINESS WIRE)--Transdermal Delivery Solutions Corporation (TDSC) www.TDSC.us announced today that pharmaceutical entrepreneur Edward J. Borkowski has joined its Board of Directors as Chair of the Audit Committee. Borkowski (https://www.linkedin.com/in/edward-j-borkowski-00b22631 ) has held the title of Chief Financial Officer for a myriad of multi-billion dollar healthcare organizations such as Mylan, Inc. ($5.5B) (NASDAQ: MYL), Carefusion Corporation ($3.5B), ConvaTec ($1.7B), and is currently CFO at Amerigen Pharmaceuticals, an early stage, private, generic pharmaceutical company.
